BRITISH AND EIRE ASSOCIATION OF VITREORETINAL SURGEONS
The objectives of the CIO are the advancement of health among those with vitreoretinal (VR) diseases and related conditions.
Objects
THE OBJECTS OF THE CIO ARE, FOR THE PUBLIC BENEFIT, THE ADVANCEMENT OF HEALTH IN PARTICULAR AMONG THOSE WITH VITREO RETINAL ("VR") DISEASES AND RELATED CONDITIONS AND IN PARTICULAR BUT WITHOUT LIMITATION BY:(A) PROMOTING HIGH QUALITY PATIENT CARE THROUGH PROMOTING BEST PRACTICE; (B) CONDUCTING AND SUPPORTING RESEARCH INCLUDING BY ESTABLISHING AND DEVELOPING NATIONAL AUDITS OF RELEVANT DISORDERS; AND(C) EDUCATING CLINICIANS, PATIENTS AND THE GENERAL PUBLIC AND IMPROVING THE UNDERSTANDING AND TREATMENT OF VR DISORDERS AND RELATED DISEASES.
Financial health, per its FY2025 accounts
The charity reported a net surplus of £26,140 for the year ended 30 September 2025, with total unrestricted funds increasing to £242,320. This figure exceeds the stated reserves policy target of £100,000, indicating a strong financial position. The accounts were prepared on a going concern basis with no material uncertainties identified.
What the accounts disclose
“The policy of the Charity is to seek to maintain reserves at a level of at least £100,000 to enable the prudent management of any unforeseen circumstances.” — page 4
“BEAVRS Trading Limited is a wholly owned trading subsidiary of the Charity, incorporated in the United Kingdom.” — page 5
Policies the charity declares
- Complaints handling
- Complaints policy and procedures
- Conflicting interests
- Financial reserves policy and procedures
- Internal charity financial controls policy and procedures
- Internal risk management policy and procedures
- Risk management
- Safeguarding policy and procedures
- Safeguarding vulnerable beneficiaries
- Trustee conflicts of interest policy and procedures
- Trustee expenses policy and procedures
Corporate structure
- Trading subsidiary: BEAVRS TRADING LIMITED Companies House 09792384 · Financial health read from its filings
Trustees
- Aman Chandra
- Assad Jalil
- Prof Dara Kilmartin
- Roxane Jo Hillier
- STEPHEN JOHN CHARLES
- Stephen Winder
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 30/09/2025 | £39k | £13k |
| 30/09/2024 | £59k | £16k |
| 30/09/2023 | £64k | £17k |
| 30/09/2022 | £38k | £10k |
| 30/09/2021 | £13k | £9k |
Common questions
Is BRITISH AND EIRE ASSOCIATION OF VITREORETINAL SURGEONS financially healthy?
Per its FY2025 accounts: The charity reported a net surplus of £26,140 for the year ended 30 September 2025, with total unrestricted funds increasing to £242,320. This figure exceeds the stated reserves policy target of £100,000, indicating a strong financial position. The accounts were prepared on a going concern basis with no material uncertainties identified. Its FY2025 accounts were independently examined.
Funders of similar charities
| Funder | Similar charities funded | Amount to them |
|---|---|---|
| BRITISH HEART FOUNDATION | 1 | £1.7m |
| HEART RESEARCH UK | 1 | £60k |
Charities like this
- BRITISH AND IRISH ORTHOPTIC SOCIETY
- BRITISH PSORIATIC ARTHRITIS CONSORTIUM CIO
- BRITISH SOCIETY OF ENDOVASCULAR THERAPY
- THE BRITISH CARDIOVASCULAR SOCIETY
- THE BRITISH ASSOCIATION OF DAY SURGERY
- THE BRITISH INSTITUTE OF RADIOLOGY
Side by side with its peers
| Charity | Income | Top pay band | Staff >£60k | Reserves vs policy | Fundraising cost | Going concern |
|---|---|---|---|---|---|---|
| BRITISH AND EIRE ASSOCIATION OF VITREORETINAL SURGEONS | £39k | — | 0 | unclear | — | no doubt |
| BRITISH AND IRISH ORTHOPTIC SOCIETY | £773k | — | 0 | below | — | no doubt |
| BRITISH PSORIATIC ARTHRITIS CONSORTIUM CIO | £25k | — | 0 | unclear | — | noted |
| BRITISH SOCIETY OF ENDOVASCULAR THERAPY | £364k | — | 0 | above | — | no doubt |
| THE BRITISH CARDIOVASCULAR SOCIETY | £3.4m | — | — | unclear | — | no doubt |
| THE BRITISH ASSOCIATION OF DAY SURGERY | £240k | — | — | unclear | — | no doubt |